Amgen (AMGN) presents positive top-line results from the Phase 3 MINT trial

FREE Breaking News Alerts from StreetInsider.com!

E-mail Address

StreetInsider.com Top Tickers, 6/23/2026

1. ABBV
2. MU
3. ACN
4. IBM
5. DPZ
6. PRIM
7. IMNN
8. NAVN
9. DFTX
10. META

Go back to Amgen (AMGN) presents positive top-line results from the Phase 3 MINT trial
Amgen Inc (NASDAQ: AMGN) Delayed: 344.72 --0 (-0%)
Previous Close $344.72    52 Week High $176.85 
Open $344.72    52 Week Low $133.64 
Day High $344.72    P/E 51.92 
Day Low $344.72    EPS $6.64 
Volume 5,717